APA (7th ed.) Citation

Piñeyro‐Garza, E., Gómez‐Silva, M., Gamino, M. E., & Delgado‐Roche, L. (2022). Bioequivalence Assessment of an Oral Fixed‐Dose Formulation of Dutasteride‐Tamsulosin 0.5 mg/0.4 mg: A Randomized, Single‐Blind, Single‐Dose, 2‐Period Crossover Study in Mexican Population Under Fasted Conditions. Clinical Pharmacology in Drug Development, 11(3), 318. https://doi.org/10.1002/cpdd.1011

Chicago Style (17th ed.) Citation

Piñeyro‐Garza, Everardo, Magdalena Gómez‐Silva, María E. Gamino, and Livan Delgado‐Roche. "Bioequivalence Assessment of an Oral Fixed‐Dose Formulation of Dutasteride‐Tamsulosin 0.5 Mg/0.4 Mg: A Randomized, Single‐Blind, Single‐Dose, 2‐Period Crossover Study in Mexican Population Under Fasted Conditions." Clinical Pharmacology in Drug Development 11, no. 3 (2022): 318. https://doi.org/10.1002/cpdd.1011.

MLA (9th ed.) Citation

Piñeyro‐Garza, Everardo, et al. "Bioequivalence Assessment of an Oral Fixed‐Dose Formulation of Dutasteride‐Tamsulosin 0.5 Mg/0.4 Mg: A Randomized, Single‐Blind, Single‐Dose, 2‐Period Crossover Study in Mexican Population Under Fasted Conditions." Clinical Pharmacology in Drug Development, vol. 11, no. 3, 2022, p. 318, https://doi.org/10.1002/cpdd.1011.